MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, CRMD has $750,861,478 in assets. $376,732,072 in debts. $48,493,076 in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
194.20%
Quick Ratio
172.56%
Cash Ratio
36.29%
Debt to Asset Ratio
50.17%
Assets Breakdown
    • Intangible assets, net
    • Trade receivables, net
    • Deferred tax assets
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Deferred tax liability
    • Others

Unit: Dollar
Balance Sheets
2025-09-30
2025-06-30
Prepaid research and development expenses
-123,116
Cash and cash equivalents
48,493,076 159,308,966
Short-term investments
7,223,735 31,402,850
Trade receivables, net
158,574,116 42,911,634
Inventories
28,916,616 9,634,438
Prepaid expenses and current assets
16,327,730 4,675,885
Total current assets
259,535,273 248,056,889
Restricted cash, long-term
-105,084
Property and equipment, net
4,347,360 1,641,152
Other long-term assets (including restricted cash of 988,233 and 105,368 at september 30, 2025, and december 31, 2024)
22,913,753 -
Goodwill
17,515,265 -
Intangible assets, net
390,011,711 1,740,260
Other assets
-642,066
Deferred tax assets
52,500,000 -
Operating lease- right-of-use assets, net
3,173,567 413,652
Finance lease- right-of-use assets, net
864,549 -
Total assets
750,861,478 252,599,103
Accounts payable
20,454,367 5,815,366
Accrued expenses
109,091,898 25,718,305
Contingent consideration, short-term
2,673,933 -
Operating lease liability, short-term
844,431 177,172
Financing lease liability, short-term
579,168 -
Total current liabilities
133,643,797 31,710,843
Deferred tax liability
144,528,552 -
Contingent consideration, net of current portion
95,591,067 -
Operating lease liabilities, net of current
2,411,243 258,073
Finance lease liabilities, net of current
557,413 -
Total liabilities
376,732,072 31,968,916
Preferred stock - 0.001 par value 2,000,000 shares authorized 91,623 and 136,623 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively
92 92
Common stock - 0.001 par value 160,000,000 shares authorized 78,349,057 and 64,411,295 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively
78,350 74,621
Accumulated other comprehensive gain
87,640 79,435
Additional paid-in capital
564,558,498 519,634,193
Accumulated deficit
-190,595,174 -299,158,154
Total stockholders equity
374,129,406 220,630,187
Total liabilities and stockholders equity
750,861,478 252,599,103
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expenses andcurrent assets$16,327,730 Inventories$28,916,616 Trade receivables,net$158,574,116 Short-term investments$7,223,735 Cash and cashequivalents$48,493,076 Finance lease-right-of-use assets, net$864,549 Operating lease-right-of-use assets, net$3,173,567 Deferred tax assets$52,500,000 Intangible assets, net$390,011,711 Goodwill$17,515,265 Other long-termassets (including...$22,913,753 Property and equipment,net$4,347,360 Total current assets$259,535,273 Total assets$750,861,478 Total liabilities andstockholders equity$750,861,478 Total stockholdersequity$374,129,406 Total liabilities$376,732,072 Accumulated deficit-$190,595,174 Additional paid-in capital$564,558,498 Finance leaseliabilities, net of current$557,413 Operating leaseliabilities, net of current$2,411,243 Contingent consideration,net of current...$95,591,067 Deferred tax liability$144,528,552 Total currentliabilities$133,643,797 Accumulated othercomprehensive gain$87,640 Common stock - 0.001 parvalue 160,000,000...$78,350 Preferred stock - 0.001 parvalue 2,000,000...$92 Financing leaseliability, short-term$579,168 Operating leaseliability, short-term$844,431 Contingent consideration,short-term$2,673,933 Accrued expenses$109,091,898 Accounts payable$20,454,367

CorMedix Inc. (CRMD)

CorMedix Inc. (CRMD)